Results 1 to 10 of about 1,084,654 (294)
Antiarrhythmic Properties of Beta Blockers: Focus on Nebivolol [PDF]
Beta-blockers are commonly used medications for cardiovascular diseases. Beta-blockers are effective antiarrhythmic agents, and they are class 2 agents in the Vaughan-Williams classification.
Bülent Görenek +7 more
doaj +2 more sources
The place of metoprolol tartrate in the treatment of cardiovascular diseases
Since the beginning of the 1960s, beta-blockers have been number one medications in the treatment of cardiovascular diseases. A number of randomized controlled trials (RCTs) demonstrated positive effect of beta-blockers on morbidity and mortality [1]. It
N. V. Romanova, I. V. Zhirov
doaj +1 more source
Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
With increasing decompensation, hyperdynamic circulatory disturbance occurs in liver cirrhosis despite activation of vasoconstrictors. Here, the concept of a therapy with non-selective beta-blockers was established decades ago. They lower elevated portal
Tilman Sauerbruch +4 more
doaj +1 more source
Beta-blockers have been considered the cornerstone of treatment for patients with acute myocardial infarction (AMI). However, long-term benefits of vasodilating beta-blockers remain uncertain.
Ki Yung Boo +11 more
doaj +1 more source
Current Knowledge of Beta-Blockers in Chronic Hemodialysis Patients
Intissar Haddiya,1,2 Siria Valoti3 1Department of Nephrology, Faculty of Medicine and Pharmacy, University Mohamed Premier, Oujda, Morocco; 2Laboratory of Epidemiology, Clinical Research and Public Health, Faculty of Medicine and Pharmacy, University ...
Haddiya I, Valoti S
doaj
Background: Some studies indicate a reduced risk of serious upper gastrointestinal bleeding (UGIB) for users of beta-blockers, but the association remains to be confirmed in larger studies and characterized with respect to differences among beta-blockers.
Mette Reilev +12 more
doaj +1 more source
Background The benefit from a blood pressure lowering therapy with beta blockers may not outweigh its risks, especially in older populations. The aim of this study was to look for evidence on risks and benefits of beta blockers in older adults and to use
Anna Vögele +8 more
doaj +1 more source
Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease
This minireview provides current summaries of beta-blocker use in the management of hypertension and/or chronic kidney disease. Accumulated evidence suggests that atenolol is not sufficiently effective as a primary tool to treat hypertension.
Hirofumi Tomiyama, Akira Yamashina
doaj +1 more source
BackgroundIt remains poorly understood whether early use of beta-blockers could provide a survival advantage in patients with critical heart failure (HF) .MethodsThis retrospective study was conducted using the American Medical Information Mart for ...
Linfeng Xie +9 more
doaj +1 more source
Study of long term structural and functional changes in medically controlled glaucoma
AIM:Prospectively analyze the long term structural and functional changes in patients of primary open angle glaucoma (POAG) receiving medical therapy (beta blockers and non beta blockers).
Achyut N Pandey, S Sujata
doaj +1 more source

